Related Experiment Video
Updated: May 11, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons
Sofie Robert1, Hannelie Korf, Conny Gysemans
1Clinical and Experimental Endocrinology, Katholieke Universiteit Leuven, Campus Gasthuisberg, Leuven, Belgium.
Islets
|May 8, 2013
Summary
Type 1 diabetes involves immune destruction of insulin-producing cells. Current immunotherapies show promise in models but face clinical translation challenges, necessitating better biomarkers and refined therapeutic strategies.
Area of Science:
- Immunology
- Endocrinology
- Translational Medicine
Background:
- Type 1 diabetes (T1D) is characterized by autoimmune destruction of pancreatic beta cells.
- This process is mediated by self-reactive CD4+ and CD8+ T cells targeting auto-antigens.
- Current clinical translation of promising animal model therapies remains unsuccessful.
Purpose of the Study:
- To provide an overview of immunomodulatory approaches for T1D.
- To focus on therapies currently in clinical evaluation.
- To highlight the need for improved biomarkers and therapeutic strategies.
Main Methods:
- Review of antigen-specific immunomodulatory therapies.
- Review of non-specific systemic immunomodulatory therapies.
- Focus on therapies verified or under clinical evaluation.
Main Results:
- Both antigen-specific and non-specific approaches have advantages and disadvantages.
- Combination therapies may offer the highest therapeutic efficacy.
- Current clinical studies lack reliable biomarkers for endpoint assessment.
Conclusions:
- Effective future strategies require well-defined biomarkers.
- Careful reconsideration of dose, timing, and frequency extrapolation from animal models to humans is crucial.
- Optimizing immunomodulatory therapies for T1D requires addressing these critical gaps.
More Related Videos
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:38What is the Immune System?
Overview
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...